Active substance
Calcium chloride
- SFDA 6
- US FDA 8
- Health Canada 5
- Safety 8
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| CALCIUM CHLORIDE 10% EMERGENCY SYRINGE | 10 % | Solution · Intravenous use | 1 Pre-filled syringe | SAR 45.45 | Generic · Prescription | HOSPIRA INC | Valid |
| CALCIUM CHLORIDE 10% I.V INFUSION | 10 % | Intravenous infusion · Intravenous use | 1 Pre-filled syringe | SAR 45.45 | Generic · Prescription | Aurum Pharmaceuticals Limited | Valid |
| CALCIUM CHLORIDE 10% INJECTION | 10 % | Solution for injection · Intravenous use | 1 Ampoule | SAR 2.00 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| CALCIUM CHLORIDE 7.35% INJECTION | 7.35 % | Solution for injection · Intravenous use | 1 Ampoule | SAR 0.80 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| CALCIUM CHLORIDE 7.35% INJECTION | 7.35 % | Solution for injection · Intravenous use | 1 Ampoule | SAR 0.70 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| CALCIUM CHLORIDE 7.35% INJECTION | 7.35 % | Solution for injection · Intravenous use | 1 Ampoule | SAR 0.55 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
Indications — CHI Daman Drug Formulary
ANESTHESIA-SUPPORTIVE AGENTS/ CARDIAC ARREST, CARDIOVASCULAR EMERGENCIES AND/OR DYSRHYTHMIAS; BRADYCARDIA; HYPERKALEMIA; HYPOPARATHYROIDISM
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER | 100MG/ML | injectable · injection | HOSPIRA | Prescription | 28 Jan 2000 |
| CALCIUM CHLORIDE 10% | 100MG/ML | injectable · injection | AM REGENT | Prescription | 27 Jul 2017 |
| CALCIUM CHLORIDE 10% | 100MG/ML | injectable · injection | INTL MEDICATION SYS | Prescription | 9 May 2018 |
| CALCIUM CHLORIDE 10% | 100MG/ML | injectable · injection | MEDEFIL INC | Prescription | 1 May 2019 |
| CALCIUM CHLORIDE 10% | 100MG/ML | injectable · injection | AMNEAL | Prescription | 8 Jul 2024 |
| CALCIUM CHLORIDE 10% | 100MG/ML | injectable · injection | PHARMAZONE | Prescription | 27 Nov 2024 |
| CALCIUM CHLORIDE 10% | 100MG/ML | injectable · injection | SOMERSET | Prescription | 17 Dec 2024 |
| CALCIUM CHLORIDE 10% | 100MG/ML | injectable · injection | SQUARE PHARMS PLC | Prescription | 29 Sep 2025 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| CALCIUM CHLORIDE FOR HAEMODIALYSIS | 02387549 | 7.45 G / VIAL | POWDER · HAEMODIALYSIS | CHIEF MEDICAL SUPPLIES LTD |
| CALCIUM CHLORIDE INJECTION USP | 00294748 | 100 MG / ML | SOLUTION · INTRAVENOUS | PFIZER CANADA ULC |
| CALCIUM CHLORIDE INJECTION USP | 00821780 | 100 MG / ML | SOLUTION · INTRAVENOUS | JUNO PHARMA CANADA INC. |
| CALCIUM-45 0.25-4.5 | 02161060 | 7.45 G / BOTTLE | POWDER FOR SOLUTION · HAEMODIALYSIS | VANTIVE ULC |
| CALCIUM-45 0.5-4.5 | 02160986 | 14.9 G / BOTTLE | POWDER FOR SOLUTION · HAEMODIALYSIS | VANTIVE ULC |
Safety signals and safety-related labeling changes
- US FDA 5 Nov 2025 LACTATED RINGER'S IN PLASTIC CONTAINER — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions - US FDA 5 Nov 2025 LACTATED RINGER'S IN PLASTIC CONTAINER — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions - US FDA 5 Nov 2025 RINGER'S IN PLASTIC CONTAINER — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions - US FDA 24 Jul 2025 KABIVEN IN PLASTIC CONTAINER — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 24 Jul 2025 PERIKABIVEN IN PLASTIC CONTAINER — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 21 Feb 2019 RINGER'S IN PLASTIC CONTAINER — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions - US FDA 30 Jun 2017 PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations - US FDA 30 Jun 2017 PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations
Combinations containing Calcium chloride
- Aluminium hydroxide + calcium chloride + menthol
- Calcium chloride + potassium chloride + sodium chloride
- Aprotinin + calcium chloride + human fibrinogen + human thrombin
- Calcium chloride + dextrose + potassium chloride + sodium chloride
- Calcium chloride + magnesium chloride + potassium chloride + sodium chloride
- Calcium chloride + magnesium chloride + sodium acetate + sodium chloride
- Calcium chloride + potassium chloride + sodium chloride + sodium lactate
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.